Paterson I, Wells GA, Ezekowitz JA, White JA, Friedrich MG, Mielniczuk LM et al. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B). Trials. 256. Persson H, Erntell H, Eriksson B, Johansson G, Swedberg K, Dahlstrom U. Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT- proBNP Guided Management of Heart Failure SIGNAL-HF (Swedish Intervention study Guidelines and NT-proBNP AnaLysis in Heart Failure). European Journal of Heart Failure. 257. Peters-Klimm F, Campbell S, Hermann K, Kunz CU, Muller-Tasch T, Szecsenyi J. Case management for patients with chronic systolic heart failure in primary care: The HICMan exploratory randomised controlled trial. Trials. 2010; 11 56 Chronic Heart Failure Reference list NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 258. Peters-Klimm F, Muller-Tasch T, Schellberg D, Gensichen J, Muth C, Herzog W et al. Rationale, design and conduct of a randomised controlled trial evaluating a primary care-based complex intervention to improve the quality of life of heart failure patients: HICMan (Heidelberg Integrated Case Management). BMC Cardiovascular Disorders. 2007; 7:25 259. Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N et al. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Circulation. 2015; 131(1):34-42 260. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM- Overall programme. Lancet. 2003; 362(9386):759-66 261. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P et al. 